Anti-Avian Influenza Neuraminidase (CT)

Home/Primary Monoclonal Antibodies/Infectious Diseases/Anti-Avian Influenza Neuraminidase (CT)

Pricing & Details

Product No.N166
Protein
Neuraminidase
Formats AvailableView All
Product Type
Polyclonal Antibody
Applications
ELISA Indirect
Prod No.
Size
Price
Avail.
Qty
Add to cart
N166-20ug
20 µg
$195.00
In stock
Max:
Min: 1
Step: 1
N166-0.1 mg
0.1 mg
$397.00
In stock
Max:
Min: 1
Step: 1
Bulk quantities available. Contact us for pricing.

Antibody Details

Product Details

Reactivity Species
Avian Influenza
Host Species
Rabbit
Product Concentration
0.5 mg/ml
Formulation
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Storage and Handling
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Rabbit Anti-Avian Influenza Neuraminidase (CT) (Neuraminidase (CT)) recognizes Avian Influenza Neuraminidase (CT). This polyclonal antibody was purified using affinity chromatography.
Background
Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA.1 Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found.2 These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong.3 There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low.4 Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the NA protein also contributes to the high virulence of the H5N1 virus.

Antigen Details

References & Citations

1. Thompson, W. W. et al. (2003) JAMA 289:179 2. Alexander, D. J. (2000) Vet. Microbiol. 74:3 3. Shortridge, K. F. et al. (1998) Virol. 252:331 4. Buxton Bridges, C. et al. (2000) J. Inf. Dis. 181:344
Indirect Elisa Protocol
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok